Loading: 100%
ENZO BIOCHEM INC logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 472 (as per Q1 2017)no data available
Sector Medical Diagnostics & Research, HealthcareMedical Diagnostics & Research, Healthcareno data available
Ticker ENZno data available
Financial year endsFY ends End of Julyno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 17036912
datesClosing price (adj.)
13.10.201710.37
11.10.201710.55
04.10.201710.50
27.09.201711.44
20.09.201710.50
13.09.201710.89
06.09.201711.29
30.08.201711.18
23.08.201711.01
16.08.201711.08
09.08.201711.18
02.08.201711.08
26.07.201711.29
19.07.201711.60
12.07.201711.36
05.07.201711.24
27.06.201711.20
20.06.201710.80
13.06.201710.21
06.06.20179.10
30.05.20178.98
23.05.20179.07
16.05.20179.21
09.05.20179.38
02.05.20178.81
25.04.20178.70
18.04.20178.52
11.04.20177.99
04.04.20178.20
28.03.20178.44
21.03.20177.87
14.03.20177.00
07.03.20176.84
28.02.20176.45
21.02.20176.71
14.02.20176.46
07.02.20176.78
31.01.20176.68
24.01.20176.79
17.01.20176.87
10.01.20177.19
03.01.20177.14
27.12.20166.98
19.12.20166.79
12.12.20166.99
05.12.20167.25
28.11.20166.92
21.11.20166.93
14.11.20166.95
07.11.20166.08
31.10.20166.10
24.10.20166.33
17.10.20165.65
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
10.37n/a
Market Capitalisation
in million USD
480n/a
Enterprise Value
in million USD
415n/a
Common Shares Outstanding
as per Oct 31, 2016
46,279,787n/a
Preferred Shares Outstanding
as per Oct 31, 2016
n/a
Average Basic Shares Outstanding
TTM
46,204,000n/a
Average Diluted Shares Outstanding
TTM
46,621,750n/a
Index Membership
n/a
Business Summary
Enzo Biochem Inc is engaged in research, development, manufacturing and marketing of health care products, platforms and services. The Company\'s business segments are Enzo Clinical Labs, Enzo Life Sciences, and Enzo Therapeutics.
no data available
Key Financials & Ratios (all figures TTM as per Oct 31, 2016, million USD, full statements further below)
Profit & Loss
Revenues 104n/a
Gross Profit 46n/a
Operating Income -4n/a
EBITDA 0n/a
Net Profit 39n/a
Balance Sheet
Cash and Cash Equivalents 67n/a
Receivables 14n/a
Total Current Assets 90n/a
PP&E 8n/a
Total Assets 110n/a
Accounts Payable 9n/a
Current Debt 2n/a
Total Current Liabilities 21n/a
Long-Term Debt 0n/a
Total Liabilities 22n/a
Total Equity 88n/a
Cash Flow
Depreciation & Amortisation 0n/a
Change in Working Capital 0n/a
Operating Cash Flow 0n/a
Net Change in PP&E and Intangibles 0n/a
Investing Cash Flow 0n/a
Dividends Paid 0n/a
Financing Cash Flow 0n/a
Total Change in Cash 0n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 44.7%n/a
Operating Margin -4.0%n/a
Net Profit Margin 37.9%n/a
Return on Equity 44.5%n/a
Return on Assets 35.7%n/a
Per Share Figures
Basic EPS 0.85n/a
Diluted EPS 0.84n/a
Sales per Share 2.25n/a
Book Value per Share 1.92n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio 12.17n/a
Price to Sales Ratio 4.61n/a
Price to Book Value 5.41n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales 3.99n/a
Book to Market Value 0.18n/a
Other Ratios
Current Ratio 435.3%n/a
Liabilities to Equity Ratio 24.8%n/a
Debt to Assets Ratio 1.8%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
97
102
103
94
96
98
103
Sales & Services Revenue
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
Cost of revenue
-52
-54
-56
-55
-54
-55
-57
Cost of Goods & Services
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
Gross Profit
45
48
47
39
42
43
46
Other Operating Income
0
0
0
0
0
0
0
Operating Expenses
-62
-57
-59
-52
-48
-47
-49
Selling, General & Administrative
-48
-45
-48
-44
-42
-41
-44
Selling & Marketing
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
Research & Development
-10
-8
-6
-4
-3
-3
-4
Depreciation & Amortization
0
0
0
0
0
0
0
Provision For Doubtful Accounts
-3
-4
-5
-4
-3
-2
-2
Other Operating Expense
0
0
0
0
0
0
0
Operating Income (Loss)
-17
-9
-12
-13
-6
-4
-4
Non-Operating Income (Loss)
0
0
0
0
0
0
0
Interest Expense, net
0
0
0
0
0
0
0
Interest Expense
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
0
0
0
0
0
0
Pretax Income (Loss), Adjusted
-17
-9
-12
-13
-6
-4
-4
Abnormal Gains (Losses)
-6
-4
-29
-6
-4
2
50
Acquired In-Process R&D
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
Pretax Income (Loss)
-22
-13
-41
-19
-10
-2
47
Income Tax (Expense) Benefit, net
0
0
2
1
0
0
-1
Current Income Tax
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
-22
-13
-39
-18
-10
-2
45
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
-22
-13
-39
-18
-10
-2
45
Minority Interest
0
0
0
0
0
0
0
Net Income
-22
-13
-39
-18
-10
-2
45
Preferred Dividends
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
-22
-13
-39
-18
-10
-2
45
Remarks
restated on Oct 15, 2012 n/a
calculated values,
restated on Oct 15, 2013 n/a
calculated values,
restated on Oct 9, 2014 n/a
calculated values,
restated on Oct 13, 2015 n/a
calculated values,
restated on Oct 13, 2016 n/a
calculated values,
restated on Oct 13, 2016 n/a
calculated values,
restated on Oct 13, 2016 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
24
15
9
17
18
68
Cash & Cash Equivalents
n/a
14
15
9
17
18
68
Short Term Investments
n/a
10
0
0
0
0
0
Accounts & Notes Receivable
n/a
15
14
12
12
12
15
Accounts Receivable, Net
n/a
15
14
12
12
12
15
Notes Receivable, Net
n/a
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
Inventories
n/a
9
9
9
9
7
7
Raw Materials
n/a
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
Other Short Term Assets
n/a
3
2
2
2
9
2
Prepaid Expenses
n/a
3
2
2
2
2
2
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
0
7
0
Total Current Assets
n/a
51
40
33
41
46
91
Property, Plant & Equipment, Net
n/a
10
9
9
8
8
8
Property, Plant & Equipment
n/a
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
Other Long Term Assets
n/a
48
20
18
16
14
12
Intangible Assets
n/a
20
12
10
8
6
4
Goodwill
n/a
27
7
7
7
7
7
Other Intangible Assets
n/a
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
0
0
0
0
0
0
Total Noncurrent Assets
n/a
58
29
26
24
22
20
Total Assets
n/a
109
69
59
64
68
112
Liabilities and owners' equity
Payables & Accruals
n/a
16 16046000
19 18838000
20 20257000
21 21162000
20 20059000
18 18068000
Accounts Payable
n/a
8 7858000
9 9020000
8 8481000
8 8245000
9 8762000
10 9857000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
8 8188000
10 9818000
12 11776000
13 12917000
11 11297000
8 8211000
Short Term Debt
n/a
0 0
0 0
3 3264000
3 3013000
3 3013000
2 1557000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
2 1683000
0 118000
0 331000
1 790000
1 886000
1 943000
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
2 1683000
0 118000
0 331000
1 790000
1 886000
1 943000
Total Current Liabilities
n/a
18 17729000
19 18956000
24 23852000
25 24965000
24 23958000
21 20568000
Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
3 3030000
1 1066000
1 974000
2 2496000
2 1830000
2 1699000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
3 2934000
1 938000
0 200000
0 183000
0 37000
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
0 96000
0 128000
1 774000
2 2313000
2 1793000
2 1699000
Total Noncurrent Liabilities
n/a
3 3030000
1 1066000
1 974000
2 2496000
2 1830000
2 1699000
Total Liabilities
n/a
21 20759000
20 20022000
25 24826000
27 27461000
26 25788000
22 22267000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
306 306223000
305 304753000
305 304694000
318 317603000
325 325427000
327 326751000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
-6 -6387000
-3 -3074000
0 0
0 0
0 0
0 0
Retained Earnings
n/a
-215 -214914000
-254 -254183000
-272 -272420000
-282 -282397000
-285 -284682000
-239 -239396000
Other Equity
n/a
4 3793000
2 1605000
2 1858000
2 1744000
2 1861000
2 2199000
Equity Before Minority Interest
n/a
89 88715000
49 49101000
34 34132000
37 36950000
43 42606000
90 89554000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
89 88715000
49 49101000
34 34132000
37 36950000
43 42606000
90 89554000
Total Liabilities & Equity
n/a
109 109474000
69 69123000
59 58958000
64 64411000
68 68394000
112 111821000
Remarks restated on n/a restated on Oct 15, 2012 n/a restated on Oct 15, 2013 n/a restated on Oct 9, 2014 n/a restated on Oct 13, 2015 n/a restated on Oct 13, 2016 n/a restated on Dec 8, 2016 n/a
Cash Flow StatementCF data quality: 4% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
-22
-13
-39
-18
-10
-2
45
Net Income
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Depreciation & Amortization
4
4
4
5
4
4
4
Non-Cash Items
14
11
63
13
12
3
12
Stock-Based Compensation
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
Change in Working Capital
-1
-6
-1
-1
0
-9
0
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
Cash from Operating Activities
-5
-4
27
-2
7
-5
61
Change in Fixed Assets & Intangibles
-3
-1
-1
-1
-1
-2
-2
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
Net Change in Long Term Investment
0
0
0
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
-1
0
0
0
0
Net Cash from Divestitures
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
Other Investing Activities
19
15
10
0
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
Cash from Investing Activities
15
14
7
-1
-1
-2
-2
Dividends Paid
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
0
0
0
3
-1
0
-2
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
0
0
0
2
12
7
0
Increase in Capital Stock
0
0
0
2
12
7
0
Decrease in Capital Stock
0
0
0
0
0
0
0
Other Financing Activities
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
Cash from Financing Activities
0
0
0
5
11
6
-2
Net Cash Before Disc. Operations and FX
11
10
35
2
17
-1
58
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
Net Cash Before FX
11
10
35
2
17
-1
58
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
Net Changes in Cash
11
10
34
2
17
-1
58
Remarks
restated on Oct 15, 2012 n/a
calculated values,
restated on Oct 15, 2013 n/a
calculated values,
restated on Oct 9, 2014 n/a
calculated values,
restated on Oct 13, 2015 n/a
calculated values,
restated on Oct 13, 2016 n/a
calculated values,
restated on Oct 13, 2016 n/a
calculated values,
restated on Oct 13, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo